What dividend earnings investors can expect from Farmaceutica REMEDIA S.A. the end of 2012 – Article from Ziarul financiar, 10.12.2012 edition.
Author: Adrian Cojocar
REMEDIA organised the seventh edition of the “Business at its home” event, dedicated to getting to know the company, after a break of 3 years.
13.02.2023 Financial Supervisory Authority Decision no 122/08.02.2023 (TRANSLATION) Name and registered office of the company concerned: The issuer / the targeted company
Farmaceutica REMEDIA received the highest score – 10, in the VEKTOR evaluation, an evaluation conducted annually by ARIR (Association for Investor Relations at the Romanian
Sursa: zfenglish.com Remedia group, with activities in drug wholesale for pharmacies, but also for clinics and private hospitals, in pharma retail and sale of robots
